Luteína: Diferenzas entre revisións

Hai tamén evidencias epidemiolóxicas de que o incremento do consumo de luteína e zeaxantina diminúe o risco de desenvolver [[catarata]]s.<ref name="PMID17846363" /><ref name=PM18332316>{{cite web |url=http://www.ncbi.nlm.nih.gov/pubmed/18332316 |title=Associations between age-related nuclear cataract and lutein and zeaxanthin in the diet and serum in the Carotenoids in the Age-Related Eye Disease Study, an Ancillary Study of the Women's Health Initiative. }}</ref> Aínda que algúns metaanálises non obtiveron resultados tan claros sobre estes beneficios.<ref name="Chong2007">{{cite journal | author = Chong EW, Wong TY, Kreis AJ, Simpson JA, Guymer RH | title = Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis | journal = [[BMJ (Clinical Research Ed.)]] | volume = 335 | issue = 7623 | page = 755 |date=October 2007 | pmid = 17923720 | pmc = 2018774 | doi = 10.1136/bmj.39350.500428.47 | url = }}</ref> O consumo de máis de 2,4&nbsp;mg de luteína/zeaxantina diariamente procedente dos alimentos ou de suplementos foi correlacionado significativamente cunha redución da incidencia das opacidades do [[cristalino]], como revelaron os datos recollidos durante un período de 13 a 15 anos no ''Nutrition and Vision Project'' (NVP).<ref>{{cite journal | pmid = 20590393 | year = 2010 | last1 = Barker Fm | first1 = 2nd | title = Dietary supplementation: effects on visual performance and occurrence of AMD and cataracts. | volume = 26 | issue = 8 | pages = 2011–23 | doi = 10.1185/03007995.2010.494549 | journal = Current medical research and opinion}}</ref>